KL*VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE*4 carriers (2021)
Attributed to:
MICA: Medical Bioinformatics: Data-Driven Discovery for Personalised Medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.neurobiolaging.2021.01.008
PubMed Identifier: 33610961
Publication URI: http://europepmc.org/abstract/MED/33610961
Type: Journal Article/Review
Parent Publication: Neurobiology of Aging
ISSN: 0197-4580